Analyst Price Targets — ACLX
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| February 25, 2026 11:35 pm | — | Guggenheim | $115.00 | $113.76 | TheFly | Arcellx downgraded to Neutral from Buy at Guggenheim |
| February 24, 2026 5:39 am | Michael Yee | UBS | $115.00 | $113.75 | StreetInsider | UBS Downgrades Arcellx Inc. (ACLX) to Neutral |
| February 24, 2026 1:12 am | Market Perform | Leerink Partners | $115.00 | $113.75 | TheFly | Arcellx downgraded to Market Perform from Outperform at Leerink |
| February 23, 2026 11:17 pm | — | Stifel Nicolaus | $115.00 | $113.75 | TheFly | Arcellx downgraded to Hold from Buy at Stifel |
| February 23, 2026 6:23 pm | Cory Kasimov | Evercore ISI | $115.00 | $113.81 | TheFly | Arcellx downgraded to In Line from Outperform at Evercore ISI |
| February 23, 2026 4:19 pm | Emily Bodnar | H.C. Wainwright | $115.00 | $113.82 | TheFly | Arcellx downgraded to Neutral from Buy at H.C. Wainwright |
| February 23, 2026 1:58 pm | — | Canaccord Genuity | $115.00 | $113.91 | TheFly | Arcellx downgraded to Hold from Buy at Canaccord |
| February 23, 2026 1:41 pm | — | Wells Fargo | $115.00 | $114.09 | TheFly | Arcellx downgraded to Equal Weight from Overweight at Wells Fargo |
| February 23, 2026 1:35 pm | — | Robert W. Baird | $115.00 | $114.10 | TheFly | Arcellx downgraded to Neutral from Outperform at Baird |
| February 23, 2026 1:24 pm | — | Truist Financial | $120.00 | $114.10 | TheFly | Arcellx downgraded to Hold from Buy at Truist |
Latest News for ACLX
ACLX share prices have soared nearly 75% in 2026 due to the recent announcement that Arcellx will be acquired. The acquisition will turn Arcellx back private, after only being on the stock market for four years.
Weekly Market HighlightsMarket breadth was slightly positive with 4,817 advancers versus 4,692 decliners, but performance was highly skewed as the mean weekly
Arcellx shares rose slightly after Gilead Sciences agreed to acquire the company for $7.8 billion, or $115 per share in cash.
Stock News Dimon warns on credit cycle: JPMorgan Chase (JPM) CEO Jamie Dimon cautioned that elevated asset prices and growing banking competition echo preâ200
NEW YORK & NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Arcellx, Inc. (NasdaqGS: ACLX) to Gilead Sciences, Inc. (NasdaqGS: GILD). Under the terms of the proposed transaction, shareholders of Arcellx will receive $115.00 per share in cash plus one contingent value right of $5.00…
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for ACLX.
U.S. House Trading
No House trades found for ACLX.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.